↓ Skip to main content

The cancer stem cell marker CD133 is a predictor of the effectiveness of S1+ pegylated interferon α-2b therapy against advanced hepatocellular carcinoma

Overview of attention for article published in Journal of Gastroenterology, August 2010
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

patent
1 patent

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
25 Mendeley
connotea
2 Connotea